The results of the current study, which show the association between the LEP (-2548) G/A and LEPR Q223R polymorphisms and breast carcinoma susceptibility and survival, suggest that the genetic basis of the potential tumor promoter role attributed to LEP and its receptor may result from certain LEP and LEPR polymorphisms. This evidence concerns the gene LEP and neoplasm.